每經(jing)訊，可(ke)恩口(kou)腔(qiang)9月12日發布公(gong)(gong)(gong)告稱(cheng)，德州(zhou)可(ke)恩口(kou)腔(qiang)醫院股(gu)(gu)份有(you)限(xian)公(gong)(gong)(gong)司(si)全資(zi)子公(gong)(gong)(gong)司(si)濟南可(ke)恩口(kou)腔(qiang)醫院有(you)限(xian)公(gong)(gong)(gong)司(si)與德州(zhou)道(dao)一醫療(liao)科技有(you)限(xian)公(gong)(gong)(gong)司(si)、自然(ran)(ran)人陳興珂擬共(gong)同出資(zi)設(she)立泰安(an)可(ke)恩醫療(liao)有(you)限(xian)公(gong)(gong)(gong)司(si)。參股(gu)(gu)公(gong)(gong)(gong)司(si)的(de)(de)注冊(ce)資(zi)本(ben)為(wei)150萬(wan)元(yuan)，其中(zhong)濟南可(ke)恩認繳(jiao)出資(zi)人民(min)(min)幣45萬(wan)元(yuan)，占注冊(ce)資(zi)本(ben)的(de)(de)30%；德州(zhou)道(dao)一認繳(jiao)出資(zi)人民(min)(min)幣75萬(wan)元(yuan)，占注冊(ce)資(zi)本(ben)的(de)(de)50%；自然(ran)(ran)人陳興珂認繳(jiao)出資(zi)人民(min)(min)幣30萬(wan)元(yuan)，占注冊(ce)資(zi)本(ben)的(de)(de)20%。參股(gu)(gu)公(gong)(gong)(gong)司(si)具(ju)體公(gong)(gong)(gong)司(si)名稱(cheng)、注冊(ce)資(zi)本(ben)、經營范圍(wei)以行政主管(guan)機關核定為(wei)準。公(gong)(gong)(gong)司(si)于2024年9月11日召開的(de)(de)第(di)四屆(jie)董事會第(di)十四次會議審(shen)議了(le)《關于對外投資(zi)設(she)立參股(gu)(gu)公(gong)(gong)(gong)司(si)的(de)(de)議案》表決結果：同意5票，根據《公(gong)(gong)(gong)司(si)章程》及(ji)相(xiang)關規定，本(ben)議案無需提交股(gu)(gu)東大會審(shen)議。

(記者 曾健輝)

免(mian)責聲明：本文內容與(yu)數據僅供參考(kao)，不構成投資(zi)建議，使用前請核實。據此操作，風(feng)險自擔(dan)。